NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

Last Price2.1100

Change-1.0400 (-33.02%)

NYSE · Last Trade: Jan 27th, 3:52 PM EST

Detailed Quote

Previous Close	3.150
Open	3.000
Bid	2.100
Ask	2.110
Day's Range	1.800 - 3.000
52 Week Range	0.4600 - 19.95
Volume	4,100,797
Market Cap	63.51M
PE Ratio (TTM)	2.425
EPS (TTM)	0.9
Dividend & Yield	0.8000 (37.91%)
1 Month Average Volume	2,092,583

About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

NovaBay Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative products for the eye care and dermatology markets. The company leverages its proprietary technology platform to create and market treatments that address unmet medical needs, primarily targeting infections and conditions that affect skin and eye health. NovaBay's product pipeline includes a range of topical antimicrobial and anti-inflammatory solutions, aiming to provide effective and safe alternatives for patients and healthcare professionals. Through its commitment to research and development, NovaBay seeks to enhance the quality of care and improve patient outcomes in various therapeutic areas. Read More

NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

Detailed Quote

Chart

About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

News & Press Releases